Bard 3DMAX Mesh | Ventralex | Sepramesh IP Hernia Patch Complications

Jan. 13, 2017 -- San Diego, CA — Hernia repair surgery is one of the most common surgical procedures performed in the United States, with more than one million conducted each year,...

Jury tacks on extra $10.5M to Teflon cancer verdict

Jan. 10, 2017 – San Diego, CA — A federal jury in Ohio has ordered DuPont to pay an additional $10.5 million to a man who developed testicular cancer after drinking...

Xarelto Bleeding Lawsuits: First bellwether trial begins in two months

Jan. 9, 2017 – San Diego, CA — The first bellwether trial in the Xarelto multidistrict litigation is set to begin this coming March. The second and third bellwethers are scheduled...

Philly judge says $13.7M verdict in Ethicon transvaginal mesh case should remain

Jan. 6, 2017 – San Diego, CA — A judge in Philadelphia said the $13.7 million verdict that came out of a transvaginal mesh case he presided over last year...

Know your risk for blood clots because treating them can be dangerous too

Jan. 5, 2017 – San Diego, CA — Blood clots can be dangerous. So can the remedies used to treat them. That’s why it’s important to know if you’re at risk...

Dallas judge slashes $1B Pinnacle hip implant verdict by half

Jan. 4, 2017 – San Diego, CA — A federal judge in Dallas cut a recent $1 billion verdict nearly in half Tuesday, lifting about $500 million worth of punitive damages...

A look into Essure’s postapproval studies

Jan. 3, 2017 – San Diego, CA — When the U.S. Food and Drug Administration convened an advisory panel meeting in September 2015 to discuss the safety and effectiveness of...

Harvard study finds trial results for majority of failed drugs are never published

Dec. 29, 2016 – San Diego, CA — Only about half of the drugs tested in humans during clinical trials actually make it to market. What happens to the results of...

N.J. town files lawsuit against DuPont, says company dodged $1.1 billion in environmental cleanup costs

Dec. 28, 2016 – San Diego, CA — DuPont is facing yet another lawsuit over alleged contamination of water and soil by a chemical the company once used to make Teflon....

J&J spent most money promoting Xarelto and Invokana to doctors

New payment data shows J&J spent $50M promoting Xarelto and Invokana to doctors last year Dec. 27, 2016 – San Diego, CA — Johnson & Johnson spent more than $28 million...